Minal Barve
- Oncology top 1%
- Molecular Biology top 10%
- Pulmonary and Respiratory Medicine top 5%
- Immunology top 5%
- Cancer Research top 5%
- Co-authors
- Karen VelasteguiJames G. ChristensenAlexander I. SpiraJohn NemunaitisNeil SenzerJoshua K. SabariRona YaegerTiciana Leal
- Topics
- Cancer Immunotherapy and Biomarkers (37 papers)Lung Cancer Treatments and Mutations (30 papers)Colorectal Cancer Treatments and Studies (30 papers)
- Cited by
- OncologyImmunologyCancer Research
- Journals
- New England Journal of MedicineJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United StatesAustraliaChina
In The Last Decade
Minal Barve
168 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Oncology 1.8k
- Molecular Biology 1.3k
- Pulmonary and Respiratory Medicine 659
- Immunology 654
- Cancer Research 444
Countries citing papers authored by Minal Barve
This map shows the geographic impact of Minal Barve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minal Barve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minal Barve more than expected).
Fields of papers citing papers by Minal Barve
This network shows the impact of papers produced by Minal Barve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minal Barve. The network helps show where Minal Barve may publish in the future.
Co-authorship network of co-authors of Minal Barve
This figure shows the co-authorship network connecting the top 25 collaborators of Minal Barve. A scholar is included among the top collaborators of Minal Barve based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minal Barve. Minal Barve is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 2 | |
| 8 | 1 | |
| 9 | 44 | |
| 10 | 1 | |
| 11 | 10 | |
| 12 | Adagrasib in Advanced Solid Tumors Harboring aKRASG12CMutationbreakdown → | 139 |
| 13 | 10 | |
| 14 | 1 | |
| 15 | 25 | |
| 16 | 5 | |
| 17 | 60 | |
| 18 | 11 | |
| 19 | 116 | |
| 20 | 237 |
About Minal Barve
Minal Barve is a scholar working on Oncology, Biotechnology and Pulmonary and Respiratory Medicine, having authored 179 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (37 papers), Lung Cancer Treatments and Mutations (30 papers) and Colorectal Cancer Treatments and Studies (30 papers). The work is most often cited by research in Oncology (1.8k citations), Immunology (654 citations) and Cancer Research (444 citations). Minal Barve has collaborated with scholars based in United States, Australia and China. Frequent co-authors include Karen Velastegui, James G. Christensen, Alexander I. Spira, John Nemunaitis, Neil Senzer, Joshua K. Sabari, Rona Yaeger, Ticiana Leal, Hirak Der‐Torossian and Melissa L. Johnson. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.